Intraoperative Bleeding
1
Pipeline Programs
3
Companies
4
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
BaxterFloseal
BaxterOstene
BaxterFloseal
Syneos HealthGATT-Patch
Clinical Trials (4)
Total enrollment: 537 patients across 4 trials
Study to Compare the Addition of Floseal to Our Standard of Care to Control Post Operative Bleeding in TKR
Start: Jan 2012Est. completion: Jan 2017132 patients
Phase 4Completed
Ostene in Thoracolumbar Decompression and Fusion Evaluated With VIBE
Start: Jan 2025Est. completion: Jun 2027173 patients
N/AEnrolling By Invitation
Benefit of Hemostatic Sealant in Preservation of Ovarian Reserve
Start: Sep 2023Est. completion: Sep 2025100 patients
N/AUnknown
GATT-Patch Versus TachoSil in Liver Surgery
Start: Aug 2022Est. completion: May 2024132 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.